ArticleBMC primary care2025
Determinants of implementation of continuous glucose monitoring for patients with Insulin-Treated type 2 diabetes: a national survey of primary care providers.
Article in BMC primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Beyond Coverage Expansion: Exploring Persistent Barriers to CGM Utilization in the Clinical Environment.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026Article
- Implementing ADA 2026 diabetes technology recommendations: opportunities and challenges for quality improvement in real-world care.BMJ open quality · 2026Article
- Continuous Glucose Monitoring Use in the Management of Type 2 Diabetes in Primary Care: Cross-Sectional Survey of Provider Comfort.JMIR formative research · 2026Article
- Barriers to use of continuous glucose monitoring among adults with type 2 diabetes.Diabetes research and clinical practice · 2026Article
- Knowledge, Attitudes, and Training Needs for AI in Primary Care: National Survey Study of Clinicians in the Veterans Health Administration.JMIR formative research · 2026Article
- Integrating Pharmacists into CGM-Enabled Digital Diabetes Care: Advancing Personalized and Data-Driven Management.Healthcare (Basel, Switzerland) · 2026Review
- Knowledge, Attitudes, and Practices Toward Continuous Glucose Monitoring Among Diabetes Educators, Nurses, and Pharmacists in Saudi Arabia: A Cross-Sectional Survey.Journal of multidisciplinary healthcare · 2026Article
- Impact of a Nurse Practitioner-Led Diabetes Program on Barriers to CGM Use in a Federally Qualified Health Center After Medicaid Expansion.Journal of diabetes research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo identify determinants of continuous glucose monitoring (CGM) implementation from primary care providers' (PCPs') perspectives and examine the associations of these determinants with both PCP intent to discuss CGM with eligible patients and facility-level uptake of CGM. STUDY
designCross-sectional survey.
methodsA survey about CGM implementation for patients with type 2 diabetes on insulin was distributed to all PCPs in the Department of Veterans Affairs (VA) health system from October 2023-April 2024. Multi-item scales measured perceived clinical benefits of CGM, workload capacity, knowledge about CGM, access to CGM resources, and support from leadership and other services. Responses were on a 5-point Likert scale from "Strongly Disagree" to "Strongly Agree". An item asked about likelihood of initiating discussions about starting CGM. Facility-level uptake was measured using VA administrative data. Multivariable regression models assessed the relationship between determinants of CGM implementation and both PCP intent to discuss CGM and facility-level uptake.
resultsOf 1373 respondents, most perceived clinical benefits of CGM (79% "Agree" + "Strongly Agree"). Very few indicated sufficient access to resources (8%) and support from leadership & other services (5%). After adjustment for respondent characteristics, the scale most strongly associated with PCP intent to discuss CGM was PCP Knowledge About CGM (B = 0.54, P <.001). Facility uptake of CGM was associated with Clinical Benefits of CGM (B = 0.10, P =.026) and Support from Leadership & Other Services (B = 0.18, P <.001).
conclusionsPCPs perceive benefits to CGM but lack sufficient knowledge, resources, and workload capacity to manage it alone. PCP education about CGM use and interprofessional support for uptake may increase the likelihood that eligible patients use CGM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.